| ID | Assay | Related subunit | Celltype | Tissue | Disease | Treatment1 | Treatment2 | Study | Download1 | Download2 |
|---|---|---|---|---|---|---|---|---|---|---|
| CDBD00914 | ChIPseq | Rad21 | SK-N-SH | Neural | Cancer | NT | NT | GSE76815 | ||
| CDBD00913 | ChIPseq | CTCF | SK-N-SH | Neural | Cancer | NT | NT | GSE76815 | ||
| CDBD00416 | ChIPseq | SMC1 | TC-32 | Neural | Cancer | NT | NT | GSE115250 | ||
| CDBD00415 | ChIPseq | SMC1 | TC-32 | Neural | Cancer | NT | NT | GSE115250 | ||
| CDBD00414 | ChIPseq | Input | TC-32 | Neural | Cancer | NT | NT | GSE115250 | ||
| CDBD00413 | ChIPseq | Input | TC-32 | Neural | Cancer | NT | NT | GSE115250 | ||
| CDBD00412 | ChIPseq | SMC1 | Kelly | Neural | Cancer | NT | shBORIS | GSE115248 | ||
| CDBD00411 | ChIPseq | SMC1 | Kelly | Neural | Cancer | NT | shBORIS | GSE115248 | ||
| CDBD00410 | ChIPseq | SMC1 | Kelly | Neural | Cancer | NT | NT | GSE115248 | ||
| CDBD00409 | ChIPseq | SMC1 | Kelly | Neural | Cancer | NT | NT | GSE115248 | ||
| CDBD00408 | ChIPseq | Input | Kelly | Neural | Cancer | NT | shBORIS | GSE115248 | ||
| CDBD00407 | ChIPseq | Input | Kelly | Neural | Cancer | NT | shBORIS | GSE115248 | ||
| CDBD00406 | ChIPseq | Input | Kelly | Neural | Cancer | NT | NT | GSE115248 | ||
| CDBD00405 | ChIPseq | Input | Kelly | Neural | Cancer | NT | NT | GSE115248 | ||
| CDBD00404 | ChIPseq | CTCF | Kelly | Neural | Cancer | NT | shBORIS | GSE115248 | ||
| CDBD00403 | ChIPseq | CTCF | Kelly | Neural | Cancer | NT | shBORIS | GSE115248 | ||
| CDBD00402 | ChIPseq | CTCF | Kelly | Neural | Cancer | NT | NT | GSE115248 | ||
| CDBD00401 | ChIPseq | CTCF | Kelly | Neural | Cancer | NT | NT | GSE115248 | ||
| CDBD00294 | ChIPseq | Input | Kelly | Neural | Cancer | NT | TAEsensitive | GSE103030 | ||
| CDBD00293 | ChIPseq | Input | Kelly | Neural | Cancer | NT | TAEsensitive | GSE103030 | ||
| CDBD00292 | ChIPseq | CTCF | Kelly | Neural | Cancer | NT | TAEsensitive | GSE103030 | ||
| CDBD00291 | ChIPseq | CTCF | Kelly | Neural | Cancer | NT | TAEsensitive | GSE103030 | ||
| CDBD00290 | ChIPseq | CTCF | Kelly | Neural | Cancer | NT | TAEresistant | GSE103030 | ||
| CDBD00289 | ChIPseq | CTCF | Kelly | Neural | Cancer | NT | TAEresistant | GSE103030 | ||
| CDBD00288 | ChIPseq | CTCF | Kelly | Neural | Cancer | JQ1 | TAEresistant | GSE103030 | ||
| CDBD00287 | ChIPseq | CTCF | Kelly | Neural | Cancer | JQ1 | TAEresistant | GSE103030 | ||
| CDBD00161 | ChIPseq | Rad21 | SK-N-SH | Neural | Cancer | NT | NT | ENCSR000EHX | ||
| CDBD00160 | ChIPseq | Rad21 | SK-N-SH | Neural | Cancer | NT | NT | ENCSR000EHX | ||
| CDBD00159 | ChIPseq | SMC3 | SK-N-SH | Neural | Cancer | NT | NT | ENCSR000EHW | ||
| CDBD00158 | ChIPseq | SMC3 | SK-N-SH | Neural | Cancer | NT | NT | ENCSR000EHW | ||
| CDBD00127 | ChIPseq | Rad21 | SK-N-SH | Neural | Cancer | Retinoic-acid | NT | ENCSR000BLY | ||
| CDBD00126 | ChIPseq | Rad21 | SK-N-SH | Neural | Cancer | Retinoic-acid | NT | ENCSR000BLY |